GM&C Life Sciences Fund logo

GM&C Life Sciences Fund

Europe, Cheshire, United Kingdom, Alderley Edge

Description

GM&C Life Sciences Fund is a provider of venture capital funds to entrepreneurs operating in the life sciences area.

Investor Profile

GM&C Life Sciences Fund has made 30 investments, with 0 in the past 12 months and 67% as lead.

Stage Focus

  • Seed (63%)
  • Series Unknown (20%)
  • Series A (10%)
  • Series B (3%)
  • Angel (3%)

Country Focus

  • United Kingdom (90%)
  • Ireland (3%)
  • Germany (3%)
  • Italy (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Medical Device
  • Life Science
  • Health Diagnostics
  • Therapeutics
  • Dental
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does GM&C Life Sciences Fund frequently co-invest with?

Alderley Park Ventures
Europe, Nottingham, United Kingdom, Nottingham
Co-Investments: 2
Deepbridge Capital
Europe, Cheshire, United Kingdom, Chester
Co-Investments: 2
MT
Europe, Manchester, United Kingdom, Manchester
Co-Investments: 1
NPIF Maven Equity Finance
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 2
NPIF – Mercia Equity Finance
Europe, Warwickshire, United Kingdom, Henley In Arden
Co-Investments: 1
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 2
Catapult Ventures
Europe, Leicester, United Kingdom, Enderby
Co-Investments: 12
Future Planet Capital
Europe, England, United Kingdom, London
Co-Investments: 2
Enterprise Equity
Europe, Louth, Ireland, Dundalk
Co-Investments: 1
J
North America, North Carolina, United States, Raleigh
Co-Investments: 1

Which angels does GM&C Life Sciences Fund often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by GM&C Life Sciences Fund?

Monument Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Monument Therapeutics develops products to treat serious diseases of the central nervous system.

BiotechnologyHealth CarePharmaceutical
SeedJul 1, 2021
Amount Raised: $3,611,747
QV Bioelectronics

Manchester, Manchester, United Kingdom

Longer, Better Quality Lives for Brain Tumour Patients

Advanced MaterialsBiotechnologyElectronicsHealth CareLife ScienceMedicalMedical DeviceNanotechnologyNeuroscience
SeedJun 30, 2021
Amount Raised: $1,016,380
Flynotes

Manchester, Manchester, United Kingdom

Flynotes is an innovative digital consent platform, improving patient safety across healthcare.

FitnessHealth CareWellness
SeedNov 24, 2020
Panthera Biopartners

Preston, Lancashire, United Kingdom

Panthera Biopartners helps pharmaceutical and contract research organizations to find the patient for clinical trials.

BiotechnologyClinical TrialsMedicalPharmaceutical
Series ASep 23, 2020
Pencil Biosciences

Alderley Park, Cheshire, United Kingdom

Pencil Biosciences is a novel gene modulation company.

BiotechnologyHealth Care
SeedDec 12, 2019
Amount Raised: $673,665
AMR Centre

Alderley Park, Cheshire, United Kingdom

AMR Centre is a joint private-public initiative to support/accelerate the development of new antibiotics and diagnostics.

BiotechnologyMedicalPharmaceutical
AngelMar 25, 2019
Amount Raised: $3,038,871
Clin-e-cal

Manchester, Manchester, United Kingdom

Clin-e-Cal is an application designes to improve inhaler technique and medication compliance.

Health CareMedical DevicePharmaceutical
Series UnknownOct 5, 2018
Biorelate

Oldham, Oldham, United Kingdom

Biorelate provides biomedical research services.

Big DataBiotechnologyHealth CareLife ScienceMedical
SeedSep 18, 2018
Amount Raised: $921,691
Nexus Labs (Surgical Teaching)

Chester, Cheshire, United Kingdom

Nexus Labs is an interactive learning resource for medical students.

E-LearningMedical
SeedAug 2, 2018
CLYZ Labs

Chester, Cheshire, United Kingdom

CLYZ Labs are developing a testing service to select the best drug therapy for personalised cancer treatment.

BiotechnologyHealth DiagnosticsLife ScienceOncologyTherapeutics
SeedApr 10, 2018